BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 6 hits of ic50 for monomerid = 273237   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Toll-like receptor 7


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.300n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair
Toll-like receptor 7


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.300n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.40n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.40n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.39E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM273237
PNG
(US10071079, Example 11 | US10478424, Example 11)
Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(N)=O)CC1)-c1cc(C)c2ncnn2c1
Show InChI InChI=1S/C25H30N6O/c1-15(2)23-20-11-18(17-6-8-30(9-7-17)13-22(26)32)4-5-21(20)29-24(23)19-10-16(3)25-27-14-28-31(25)12-19/h4-5,10-12,14-15,17,29H,6-9,13H2,1-3H3,(H2,26,32)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.39E+3n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair